Navigation Links
Chemicals remaining after wastewater treatment change the gender of fish
Date:6/21/2010

Male fish that used to be feminized after chemicals, such as the pharmaceutical ethinylestradiol, made it through the Boulder, Colo., Wastewater Treatment Plant and into Boulder Creek, are taking longer to become feminized after a plant upgrade to an activated sludge process, according to a new study. The results will be presented Sunday at The Endocrine Society's 92nd Annual Meeting in San Diego.

Although the levels of the chemicals that the fish swam in were very low even before the upgrade, the chemicals are endocrine disrupters. They mimic estrogen and may disrupt the endocrine (hormone) system of both animals and humans, said the study's principal investigator, David Norris, PhD, an integrative physiology professor at the University of Colorado at Boulder.

Norris' team reported in 2006 that native male fish in Boulder Creek decreased in numbers with respect to females and numerous intersex fish were found downstream of the wastewater treatment plant. After a technology upgrade to the wastewater treatment plant in 2008, the reproductive disruption in the fish was far less pronounced. However, Norris said the study results should still concern people.

"The fish are a wake-up call," Norris said. "Our bodies and those of the much more sensitive human fetus are being exposed everyday to a variety of chemicals that are capable of altering not only our development and physiology but that of future generations as well."

With other scientists, Norris studied samples of the wastewater effluent, the plant-treated water that enters the stream and becomes another city's drinking water. Grants from the U.S. Environmental Protection Agency (EPA) and the city of Boulder supported this research.

They found other endocrine disrupters, including synthetic and natural reproductive steroids. They believe the chemicals come from natural female hormones and birth control pills excreted via urine and from detergents, cosmetics and other consumer products flushed down toilets and drains. The amount of estrogens in the sampled effluent was enough to explain the effects on the fish "downstream" from the treatment plantin the river below the plant, according to Norris. The researchers saw no signs of reproductive disruption in fish upstream.

Also, the investigators exposed adult male fathead minnows to wastewater effluent they diluted with water taken from upstream of the plant. After seven days' exposure to this water, the fish had suppressed male sex characteristics and greatly elevated levels of the protein vitellogenin. Female fish make vitellogenin under the influence of estrogens, and male fish produce very little of it, so elevated levels in males indicate estrogen exposure, Norris explained.

After the technology upgrade to the wastewater treatment plant in 2008, the effluent was considerably less estrogenic to the fish. After the treatment plant's upgrade, the minnows exhibited less intense loss of male sex characteristics, an initial analysis found. "It took 28 days to get a significant elevation in vitellogenin and then only in 100 percent effluent," Norris said. "However, these improvements seen in wildlife will not substantially lessen the risk to human health because drinking water is not the major source of estrogenic chemicals for people."


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. Chemicals that eased one environmental problem may worsen another
2. More Cancer-Causing Chemicals in U.S. Cigarettes
3. Better animal-free test for chemicals that can cause contact dermatitis
4. Prenatal Exposure to Chemicals Linked to Breast Cancer Risk
5. Natural Chemicals Act As Cancer Killers
6. Endocrine-disrupting chemicals pose cancer risk
7. Prenatal exposure to endocrine-disrupting chemicals linked to breast cancer
8. Selenium Helped Cells Reboot After Exposure to Cancer-Causing Chemicals
9. Two New Phytochemicals with Anti-Inflammatory Activity Found in Noni Fruit
10. Chemicals in Beauty Products Tied to Early Puberty in Girls
11. Exposure to 3 classes of common chemicals may affect female development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in ... a special report in the May issue of Consumer Reports focused on heart health. ... for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... instrument solutions, announces the continuation of its strategic partnership with and platinum sponsorship ... developing nations in the safe and effective management of complex spine deformity cases, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s ... bundles, which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology: